Speaker line-up of 2023
![](https://amr-conference.com/wp-content/uploads/2023/02/ACameron-384x400.png)
Alexandra Cameron
Senior Expert, Unit Head A.I. Impact Initiatives and Research Coordination, AMR Division, World Health Organization
![](https://amr-conference.com/wp-content/uploads/2023/01/Kerscher-370x400.jpg)
Bernhard Kerscher
Head of Laboratory & Preclinical Assessor, Paul-Ehrlich-Institut - German Federal Institute for Vaccines and Biomedicines
![](https://amr-conference.com/wp-content/uploads/2023/01/Morel-400x400.jpg)
Chantal Morel
Health economist in anti-microbial resistance, KPM Center for Public Management, University of Bern
![](https://amr-conference.com/wp-content/uploads/2023/11/Dehio-400x400.jpg)
Christoph Dehio
Full Professor of Molecular Microbiology, Director of National Centre of Competence in Research (NCCR) “AntiResist”
![](https://amr-conference.com/wp-content/uploads/2023/02/Boersma-400x400.jpg)
Cornelis Boersma
Professor Sustainable Health and Innovation, Netherlands Antibiotic Development Platform (NADP)
![](https://amr-conference.com/wp-content/uploads/2023/02/Gary-scaled-e1675957722732-400x400.jpg)
Dominik Gary
Chief Development Officer, fzmb GmbH - Research Center for Medical Technology and Biotechnology
![](https://amr-conference.com/wp-content/uploads/2023/01/Biagini-400x400.jpg)
Giancarlo Biagini
Head of the Department of Tropical Disease Biology, Liverpool School of Tropical Medicine
![](https://amr-conference.com/wp-content/uploads/2023/02/Poolman-400x400.jpg)
Jan Poolman
Vice-President, Head Bacterial Vaccine Discovery and Early Development, Janssen Vaccines & Prevention B.V.
![](https://amr-conference.com/wp-content/uploads/2023/02/Walia-400x400.jpg)
Kamini Walia
Senior Scientist at Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research
![](https://amr-conference.com/wp-content/uploads/2019/12/Outterson-400x400.png)
Kevin Outterson
Austin B Fletcher Professor, Boston University, and Executive Director & Principal Investigator, CARB-X
![](https://amr-conference.com/wp-content/uploads/2023/01/Jones-1-400x400.jpg)
Mark Jones
Head of Development, Basilea Pharmaceutica International Ltd | BEAM Alliance - Board Member | Swiss Round Table for Antibiotics - Board Member
![](https://amr-conference.com/wp-content/uploads/2023/01/Vanbiervliet-400x400.jpg)
Morgane Vanbiervliet
Manager, Market Intelligence & Business Development, Infectious Diseases, Debiopharm International SA
![](https://amr-conference.com/wp-content/uploads/2023/03/Heinrich-400x400.jpg)
Norbert Heinrich
Unit head for TB diagnostic and treatment trials, Ludwig-Maximilians-University of Munich
![](https://amr-conference.com/wp-content/uploads/2023/02/Arrazuria-400x400.jpg)
Rakel Arrazuria
Researcher, Microbiology Division, Paul-Ehrlich-Institut - German Federal Institute for Vaccines and Biomedicines
![](https://amr-conference.com/wp-content/uploads/2023/02/Ferrer-400x400.jpg)
Santiago Ferrer Bazaga
Investigator and Scientific Advisor for Drug Discovery, Universidad Carlos III de Madrid
![](https://amr-conference.com/wp-content/uploads/2023/02/Itani-400x400.jpg)
Tetsuya Itani
Director, Office of Global Health Cooperation, Ministry of Health, Labour and Welfare, Japan
![](https://amr-conference.com/wp-content/uploads/2023/01/Ferrisse-400x400.jpg)
Yann Ferrisse
Director, Business Development & Partner Engagement, Global Access at Global Antibiotic R&D Partnership (GARDP)
![](https://amr-conference.com/wp-content/uploads/2023/01/Gitai-400x400.jpg)
Zemer Gitai
EG Conklin Professor, Department of Molecular Biology, Princeton University and Founder, ArrePath Inc.